Home / Brands / Preferred Pharmaceuticals
Preferred Pharmaceuticals Recalls
55 recalls on record · August 29, 2018 to April 15, 2026 · Drugs
Recalls by year
18
19
20
21
22
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 27, 2022DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bottle, Rx Only, Mfg: Sola Pharmaceutical, Pre
Hazard: CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.
April 20, 2022DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Econazole Nitrate Cream, 1%, Generic for Spectazole, 30 gm tube, Rx Only, Preferred Pharmaceuticals, Inc., The Physican'
Hazard: CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
April 20, 2022DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prev
Hazard: Out of specification results observed in dissolution during long term stability testing.
April 20, 2022DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent Pharma, Inc., PREFERRED
Hazard: CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.
March 9, 2022DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets pe
Hazard: CGMP deviations
December 22, 2021DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Diclofenac Sodium Topical Solution, 1.5% w/w, packaged in 150 mL bottles, Rx only, Mfg: SOLA Pharmaceuticals Preferred P
Hazard: Defective container: Out of specification for container integrity leading to bottles leaking.
May 26, 2021DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg
Hazard: CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.
May 5, 2021DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only,
Hazard: Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin
November 25, 2020DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.;
Hazard: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
September 30, 2020DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Nature-Throid, 1.5 Grain, (97.5 mg), (Thyroid U.S.P. 1.5 gr. (97.5mg)/Liothyronine (T3) 13.5mcg/Levothyroxine (T4) 57mcg
Hazard: CGMP Deviations
September 30, 2020DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Nature-Throid, 1 Grain, 65 mg (Thyroid U.S.P. 1 gr. (65mg)/Liothyronine (T3) 9mcg/Levothyroxine (T4) 38mcg, packaged in
Hazard: CGMP Deviations
September 30, 2020DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Nature-Throid, 3/4 Grain (48.75 mg) Thyroid U.S.P. 3/4 gr. (48.75 mg)/Liothyronine (T3) 6.75mcg/Levothyroxine (T4) 28.5m
Hazard: CGMP Deviations
September 30, 2020DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Nature-Throid, 1/2 Grain, 32.5 mg (Thyroid U.S.P. 1/2 gr. (32.5 mg)/Liothyronine (T3) 4.5mcg/Levothyroxine (T4) 19mch, 1
Hazard: CGMP Deviations
July 22, 2020DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Lidothol Patch, Lidocaine 4.5% & Menthol 5%, In each patch: lidocaine 4.5% topical anesthetic, menthol 5% topical analge
Hazard: CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.
July 8, 2020DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc.,
Hazard: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
January 29, 2020DrugsFDA
Preferred Pharmaceuticals, Inc recalls Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 coun
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
January 29, 2020DrugsFDA
Preferred Pharmaceuticals, Inc recalls Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
December 18, 2019DrugsFDA
Preferred Pharmaceuticals, Inc recalls Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06), M
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
December 4, 2019DrugsFDA
Preferred Pharmaceuticals, Inc recalls Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg:
Hazard: Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
October 2, 2019DrugsFDA
Preferred Pharmaceuticals, Inc recalls Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anahe
Hazard: Failed Impurities/Degradation Specifications
July 31, 2019DrugsFDA
Preferred Pharmaceuticals, Inc recalls Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 g Tube, Gen
Hazard: CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
June 26, 2019DrugsFDA
Preferred Pharmaceuticals, Inc recalls Robafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextromethorphan HBr, USP 10mg,/Guaifenesin, USP 100mg
Hazard: CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
May 22, 2019DrugsFDA
Preferred Pharmaceuticals, Inc recalls Losartan Potassium Tab. USP 50mg, a) 30 count bottle (NDC 68788-0048-03) and b) 90 count bottle (NDC 68788-0048-09), Rx
Hazard: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
March 27, 2019DrugsFDA
Preferred Pharmaceuticals, Inc recalls Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC: 68788-0048-09)
Hazard: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.
August 29, 2018DrugsFDA
Preferred Pharmaceuticals, Inc recalls Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250 N
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.